Combination Treatment With VELCADE and Low-Dose Tissue Plasminogen Activator Provides Potent Neuroprotection in Aged Rats After Embolic Focal Ischemia * Supplemental Methods
Stroke - United States
doi 10.1161/strokeaha.109.577288
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2010
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)